Navigation Links
Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
Date:1/30/2013

PARSIPPANY, N.J., Jan. 30, 2013 /PRNewswire/ -- Ferring Pharmaceuticals was one of 54 honorees receiving WorldatWork's Alliance for Work-Life Progress (AWLP) 2013 Work-Life Seal of Distinction.  The award recognizes both public and private sector organizations from a variety of industries that have shown leadership in workplace strategies and practices to achieve success in work-life effectiveness.

"Ferring values the commitment that our colleagues make to the company," said Aaron Graff , President and COO of Ferring Pharmaceuticals Inc.  "We also know how important it is to establish a Ferring culture which allows us to balance work life with home life, and we are proud to be designated as a national leader in this regard."

Applicants for the AWLP seal were evaluated based on their work-life portfolio, including areas spanning dependent care, health and wellness, workplace flexibility, financial support, paid and unpaid time off, community involvement and efforts to transform organizational culture. 

Some of the specific programs of note offered at Ferring include:

  • Wellness initiatives, such as fitness related subsidies, on-site immunization clinics and a branded wellness program
  • Opportunities for workplace flexibility (e.g., flextime, phased return-to-work after FMLA-eligible leave)
  • Financial support through reimbursement of adoption and tuition expenses and college scholarships for employees' children
  • Company-sponsored retirement programs, including a traditional 401(k) match program and a supplemental employer-funded retirement plan
  • Community volunteer opportunities

For more details regarding the Work-Life Seal of Distinction, please visit http://www.awlp.org/awlp/seal/index.html.  To learn more about the Ferring Pharmaceuticals, visit www.ferringUSA.com.

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit www.ferringUSA.com.


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
2. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
3. Morgan & Morgan Announces Investigation of MAP Pharmaceuticals (NASDAQ: MAPP)
4. Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock
5. Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call
6. Keryx Biopharmaceuticals Announces $55 Million Proposed Public Offering of Common Stock
7. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
8. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
9. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
10. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
11. Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... "Company") (NASDAQ: UNIS ; ASX: UNS), a developer and ... for the second quarter of fiscal 2016 (three months ended December ... Financial Results for the Second Quarter of Fiscal 2016 ... the second quarter of fiscal 2016 was $4.5 million, compared to ... customers for the second quarter of fiscal 2016 were $17.8 million, ...
(Date:2/9/2016)... QGEN ; Frankfurt Prime ... Genomics to develop and promote comprehensive solutions for ... --> QGEN ; Frankfurt Prime Standard: QIA) ... develop and promote comprehensive solutions for next-generation sequencing ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ...
(Date:2/9/2016)... , February 9, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and ... featured presenting company at Source Capital Group,s 2016 Disruptive ... 10-11, 2016 in New York City ... February 10, 2016 at 12:30 pm by Gerald ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... The ... 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | Ticket ... Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation , ...
(Date:2/10/2016)... DC (PRWEB) , ... February 10, 2016 , ... Anxiety ... level since the start of Medicare Part D a decade ago, according to ... comments from older adults on how they are coping with rapidly rising costs. ...
(Date:2/10/2016)... ... February 09, 2016 , ... According to a recent article ... the number of patients under the age of 30. According to Southern California based ... offices, and may indicate an overall shift in the rapidly growing social acceptance of ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... Medicaid beneficiaries who are diagnosed with autism spectrum disorder (ASD). Beginning Jan. 1, ... treatment using applied behavior analysis (ABA) is key to providing effective treatment for ...
(Date:2/9/2016)... MA (PRWEB) , ... February 09, 2016 , ... ... (WCRI) compares the workers’ compensation fee schedule rates and Medicare rates for a ... services covered in the report, Evaluation of the 2015 Fee Schedule Rates ...
Breaking Medicine News(10 mins):